WOUND-HEALING COMPLICATIONS AFTER KIDNEY TRANSPLANTATION: A PROSPECTIVE, RANDOMIZED COMPARISON OF SIROLIMUS AND TACROLIMUS1
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Sirolimus has been associated with an increased risk of wound-healing complications in several retrospective analyses. The authors compared the rates of wound-healing complications in renal allograft recipients in a prospective, randomized trial of sirolimus-mycophenolate mofetil-prednisone versus tacrolimus-mycophenolate mofetil-prednisone. METHODS: All patients received antithymocyte globulin induction. In the first phase of the study, patients (n = 77) were included regardless of body mass index (BMI). In the second phase (n = 46 patients), the authors excluded patients with a BMI greater than 32 kg/m2, and the target trough sirolimus level was lowered to 10 to 15 ng/mL (previously 15-20 ng/mL). Multivariate logistic regression analyses were performed to identify predictors of wound complications. RESULTS: Fifty-nine patients received tacrolimus and 64 received sirolimus and were included in subsequent analyses. The incidence of complications was 8% (5 of 59) in the tacrolimus group and 47% (30 of 64) in the sirolimus group (P < 0.0001). Rates of perigraft fluid collections, superficial wound infections, and incisional herniae were significantly higher in the sirolimus group. Multivariate logistic regression showed only sirolimus (P = 0.0001) and BMI (P = 0.0021) to independently correlate with complications. In the first phase of the study, the wound complication rate in the sirolimus group was 55% (21 of 38 patients). After excluding obese recipients and decreasing the target sirolimus level, the wound complication rate in the sirolimus group was 35% (9 of 26 patients; P = 0.1040). CONCLUSIONS: The use of sirolimus-based immunosuppressive regimens leads to a higher incidence of wound-healing complications and will require new approaches to patient selection and management to decrease their incidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Horan, T. C., Gaynes, R. P., Martone, W. J., Jarvis, W. R., & Grace Emori, T. (1992) · American Journal of Infection Control · doi:10.1016/s0196-6553(05)80201-9 · Cited by 2,609
Horan, T. C., Gaynes, R. P., Martone, W. J., Jarvis, W. R., & Emori, T. G. (1992) · Infection Control and Hospital Epidemiology · doi:10.2307/30148464 · Cited by 1,167
Kahan, B. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02480-6 · Cited by 913
MacDonald, A. S. (2001) · Transplantation · doi:10.1097/00007890-200101270-00019 · Cited by 621
Humar, R., Kiefer, F. N., Berns, H., Resink, T. J., & Battegay, E. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0658com · Cited by 381
Flechner, S. M., Goldfarb, D., Modlin, C., Feng, J., Krishnamurthi, V., Mastroianni, B., Savas, K., Cook, D. J., & Novick, A. C. (2002) · Transplantation · doi:10.1097/00007890-200210270-00002 · Cited by 375
CHARACTERISTICS OF SIROLIMUS-ASSOCIATED INTERSTITIAL PNEUMONITIS IN RENAL TRANSPLANT PATIENTS
Morelon, E., Stern, M., Israel-Biet, D., Correas, J.-M., Danel, C., Mamzer-Bruneel, M.-F., Peraldi, M.-N., & Kreis, H. (2001) · Transplantation · doi:10.1097/00007890-200109150-00008 · Cited by 274
Demographics and trends in overweight and obesity in patients at time of kidney transplantation
Friedman, A. N., Miskulin, D. C., Rosenberg, I. H., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50059 · Cited by 253
Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity
Kahan, B., Napoli, K., Kelly, P., Podbielski, J., Hussein, I., Urbauer, D., Katz, S., & Van Buren, C. (2000) · Clinical Transplantation · doi:10.1034/j.1399-0012.2000.140201.x · Cited by 246
The effect of obesity on renal transplant outcomes
Johnson, D. W., Isbel, N. M., Brown, A. M., Kay, T. D., Franzen, K., Hawley, C. M., Campbell, S. B., Wall, D., Griffin, A., & Nicol, D. L. (2002) · Transplantation · doi:10.1097/00007890-200209150-00015 · Cited by 242
Valente, J. F., Hricik, D., Weigel, K., Seaman, D., Knauss, T., Siegel, C. T., Bodziak, K., & Schulak, J. A. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00185.x · Cited by 241
Gonwa, T., Mendez, R., Yang, H. C., Weinstein, S., Jensik, S., & Steinberg, S. (2003) · Transplantation · doi:10.1097/01.tp.0000062837.99400.60 · Cited by 187
Oberbauer, R., Kreis, H., Johnson, R. W. G., Mota, A., Claesson, K., Ruiz, J. C., Wilczek, H., Jamieson, N., Henriques, A. C., Paczek, L., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000074360.62032.39 · Cited by 182
Langer, R. M., & Kahan, B. D. (2002) · Transplantation · doi:10.1097/00007890-200209270-00012 · Cited by 162
Hong, J. C., & Kahan, B. D. (2000) · Transplantation · doi:10.1097/00007890-200005270-00019 · Cited by 162
Interstitial Pneumonitis Associated with Sirolimus Therapy in Renal-Transplant Recipients
Morélon, E., Stern, M., & Kreis, H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430317 · Cited by 150
Delayed Wound Healing with Sirolimus After Liver Transplant
Guilbeau, J. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a128 · Cited by 84
Akselband, Y., Mw, H., & Nelson, P. A. (1991) · PubMed · Cited by 84
Obesity favors surgical and infectious complications after renal transplantation
Espejo, B., Torres, A., Valentín, M., Bueno, B., Andrès, A., Praga, M., & Morales, J. M. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00718-8 · Cited by 62
Charpentier, B., Groth, C. G., Bäckman, L., Morales, J. M., Calne, R. Y., Kreis, H., Lang, P., Touraine, J. L., Claesson, K., Campistol, J. M., et al. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00213-6 · Cited by 29
Cited by
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
Ekberg, H., Tedesco-Silva, H., Demirbas, A., Vítko, Š., Nashan, B., Gürkan, A., Margreiter, R., Hugo, C., Grinyó, J. M., Frei, U., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067411 · Cited by 1,810
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Taylor, A. L., Watson, C. J. E., & Bradley, J. A. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.03.012 · Cited by 445
Webster, A. C., Lee, V. W. S., Chapman, J. R., & Craig, J. C. (2006) · Transplantation · doi:10.1097/01.tp.0000219703.39149.85 · Cited by 335
Larson, T. S., Dean, P. G., Stegall, M. D., Griffin, M. D., Textor, S. C., Schwab, T. R., Gloor, J. M., Cosio, F. G., Lund, W. J., Kremers, W. K., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01177.x · Cited by 299
Self-citation
Metadata
- Authors
- Dean, P. G., Lund, W. J., Larson, T. S., Prieto, M., Nyberg, S. L., Ishitani, M. B., Kremers, W. K., & Stegall, M. D.
- Venue
- Transplantation
- Published
- 2004-05-27
- Volume
- 77
- Issue
- 10
- Pages
- 1555-1561
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1984001665
- Cited by
- 332
- References
- 21
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.